CoChat

Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Patients with diabetes are at increased risk of severe influenza disease; influenza vaccination for these patients is therefore recommended by the World Health Organization and several National Immunization Technical Advisory Groups. However, no systematic review has evaluated the effects of influenza vaccines for patients with diabetes. METHODS: We conducted a systematic review and meta-analysis by searching Medline, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov from inception until November 2014. We included all types of studies reporting on the efficacy, effectiveness, and/or safety of influenza vaccination in patients with type 1 and type 2 diabetes of all ages. We used the Newcastle-Ottawa scale to assess risk of bias in observational studies. Residual confounding was addressed by comparing estimates of vaccine effectiveness (VE) during influenza seasons to those obtained during off-seasons. Quality of the evidence for each outcome was assessed using the GRADE methodology. RESULTS: Following review of 1,444 articles, 11 observational studies with a total of 170,924 participants were included. In diabetic patients of working-age (18-64 years), influenza vaccination prevented all-cause hospitalization with a pooled VE of 58% (95% CI, 6-81%) and hospitalization due to influenza or pneumonia (VE 43%; 95% CI, 28-54%), whereas no effects on all-cause mortality and influenza-like illness (ILI) were observed. In the elderly (65+), influenza vaccination prevented all-cause mortality (VE 38%; 95% CI, 32-43%), all-cause hospitalization (VE 23%; 95% CI, 1-40%), hospitalization due to influenza or pneumonia (VE 45%; 95% CI, 34-53%), and ILI (VE 13%; 95% CI, 10-16%). However, significant off-season estimates for several outcomes indicated residual confounding, particularly in elderly patients. Quality of the evidence was low to very low for all outcomes. Laboratory-confirmed influenza infections were not reported. CONCLUSIONS: Due to strong residual confounding in most of the identified studies, the available evidence is insufficient to determine the magnitude of benefit that diabetic people derive from seasonal influenza vaccination. Adequately powered randomized controlled trials or quasi-experimental studies using laboratory-confirmed influenza-specific outcomes are urgently needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-015-0295-6

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart for the systematic literature search and study selection related to efficacy, effectiveness, and safety of influenza vaccines in diabetic patients.
Figure 1 Flow chart for the systematic literature search and study selection related to efficacy, effectiveness, and safety of influenza vaccines in diabetic patients.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 1

  1. Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, et al. Influenza vaccine effectiveness against hospitalisation and death in people with Type 2 diabetes. Wiley-Blackwell; 2014, p. 74–75. http://onlinelibrary.wiley.com/doi/10.1111/dme.12378_2/pdf . · doi:10.1111/dme.12378_2/pdf

Cited by

See all 115

Metadata

Authors
Remschmidt, C., Wichmann, O., & Harder, T.
Affiliations
Robert Koch Institute (DE)
Corresponding author
Remschmidt, Cornelius
Venue
BMC Medicine
Published
2015-03-17
Volume
13
Issue
1
Pages
53-53
ISSN
1741-7015 (ISSN-L)
OpenAlex
W2031022865
Cited by
115
References
68
Citations by year
2026: 5 · 2025: 10 · 2024: 7 · 2023: 13 · 2022: 12 · 2021: 11 · 2020: 16 · 2019: 6 · 2018: 10 · 2017: 10 · 2016: 14 · 2015: 1
FWCI
1.52
Type
journal article
Language
en
Open access
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion)
Funders
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Robert Koch Institut
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
influenza vaccination, seasonal influenza, diabetes mellitus, type 1 diabetes, type 2 diabetes, vaccine effectiveness, hospitalization, mortality, influenza-like illness, pneumonia, older adults, residual confounding
MeSH terms
Aged, Aged, 80 and over, Diabetes Mellitus, Female, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Middle Aged, Vaccination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12916-015-0295-6
The paper
Remschmidt, C., Wichmann, O., & Harder, T. (2015). Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Medicine. https://doi.org/10.1186/s12916-015-0295-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.